Saccharin Increases Fasting Blood Glucose but Not Liver Insulin Resistance in Comparison to a High Fructose-Fed Rat Model
暂无分享,去创建一个
I. Barshack | E. Grossman | E. Peleg | A. Bier | A. Leibowitz | M. Gilboa
[1] P. Metrakos,et al. Non-alcoholic fatty liver disease--a chronic disease of the 21st century , 2018, Journal of biomedical research.
[2] Michelle Fiander,et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies , 2017, Canadian Medical Association Journal.
[3] Joshua A. Salomon,et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.
[4] D. Prabhakaran,et al. 20-Year Trend of Cardiovascular Disease Risk Factors , 2017 .
[5] Y. Ni,et al. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments , 2017, Nutrients.
[6] M. Fornage,et al. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.
[7] Mi-Sung Kim,et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. , 2016, The Journal of clinical investigation.
[8] C. Sirlin,et al. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[9] M. Alkafafy,et al. Impact of aspartame and saccharin on the rat liver: Biochemical, molecular, and histological approach , 2015, International journal of immunopathology and pharmacology.
[10] Mats Fredrikson,et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.
[11] K. Amin,et al. Alterations in lipid profile, oxidative stress and hepatic function in rat fed with saccharin and methyl-salicylates. , 2015, International journal of clinical and experimental medicine.
[12] E. Segal,et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota , 2014, Nature.
[13] O. MacDougald,et al. Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females. , 2014, Endocrinology.
[14] S. Swithers. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements , 2013, Trends in Endocrinology & Metabolism.
[15] H. Makhlouf,et al. Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) , 2013, Digestive Diseases and Sciences.
[16] I. Samojlik,et al. The influence of chronic intake of saccharin on rat hepatic and pancreatic function and morphology: gender differences. , 2013, Bosnian journal of basic medical sciences.
[17] M. Blüher,et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism , 2012, Nature.
[18] L. Schmidt,et al. Public health: The toxic truth about sugar , 2012, Nature.
[19] R. Ness-Abramof. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial , 2012 .
[20] I. Barshack,et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. , 2011, Journal of hepatology.
[21] E. Rimm,et al. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. , 2011, The American journal of clinical nutrition.
[22] A. Khera,et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.
[23] J. Schwarz,et al. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome , 2010, Nature Reviews Gastroenterology &Hepatology.
[24] D. Jacobs,et al. Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA) , 2009, Diabetes Care.
[25] C. McClain,et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. , 2008, Journal of hepatology.
[26] J. Stevens,et al. Dietary Intake and the Development of the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study , 2008, Circulation.
[27] J. Goldstein,et al. Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.
[28] G. Link,et al. Fructose-Induced Fatty Liver Disease: Hepatic Effects of Blood Pressure and Plasma Triglyceride Reduction , 2005, Hypertension.
[29] G. Marchesini,et al. Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.